Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
ally bridge group
archive
big data analytics
biotech
blackrock
boston
boston blog main
boston top stories
casdin capital
clinical trials
coronavirus
covid-19
diabetic nephropathy
eventide asset management
focal segmental glomerulosclerosis
goldfinch bio
insights
irving investors
jay ghosh
life sciences
medical
national blog main
national top stories
research
schroeder adveq
science
software
study
third rock ventures
wellington management company
yonjin capital
What
drug
4
×
studies
4
×
doesn’t
drugs
medicine
use
actual
actually
analysis
analyzed
anesthetic
aren’t
behalf
bio
biotech
blood
bring
calgary’s
canadian
cannabis
certain
citizens
clement
company
concluded
coronavirus
cummings
current
dangers
depression
determine
develop
diseases
employing
factors
finds
fiona
genetic
goal
goldfinch
Language
unset
4
×
Current search:
studies
×
unset
×
drug
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@slashgear.com
3 years ago
Ketamine treatment for major depression: Study finds serotonin is key
@bgr.com
4 years ago
A drug thought to worsen coronavirus infections might actually help people recover
@thenextweb.com
4 years ago
Here’s what the actual research says about the dangers of cannabis use